LEU-697 -] VAL MUTATION IN MATURE VON-WILLEBRAND-FACTOR IS RESPONSIBLE FOR TYPE-IIB VON-WILLEBRAND DISEASE

被引:0
|
作者
HILBERT, L
GAUCHER, C
DEROMEUF, C
HORELLOU, MH
VINK, T
MAZURIER, C
机构
[1] CTR REG TRANSFUS SANGUINE,RECH HEMOSTASE LAB,F-59012 LILLE,FRANCE
[2] HOP HOTEL DIEU,SERV HEMATOL,PARIS,FRANCE
[3] UNIV HOSP UTRECHT,DEPT HAEMATOL,3508 GA UTRECHT,NETHERLANDS
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:1542 / 1550
页数:9
相关论文
共 50 条
  • [31] TYPE-2 VON-WILLEBRAND DISEASE RESULTING FROM AN INSERTION OR DELETION IN THE 509-695 DISULFIDE LOOP OF VON-WILLEBRAND-FACTOR
    GAUCHER, C
    HILBERT, L
    MERIANE, F
    MAZURIER, C
    PERNOD, G
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1168 - 1168
  • [32] NEW VARIANT OF VON-WILLEBRAND DISEASE TYPE-II WITH MARKEDLY INCREASED LEVELS OF VON-WILLEBRAND FACTOR ANTIGEN AND DOMINANT MODE OF INHERITANCE - VON-WILLEBRAND DISEASE TYPE-IIC MIAMI
    LEDFORD, MR
    RABINOWITZ, I
    SADLER, JE
    KENT, JW
    CIVANTOS, F
    BLOOD, 1993, 82 (01) : 169 - 175
  • [33] A NOVEL VON-WILLEBRAND-FACTOR, ARG611CYS OR VWF COLUMBIA, ASSOCIATED WITH A DOMINANT VON-WILLEBRAND DISEASE VARIANT
    HAKAMI, N
    SHIBUYA, H
    JOHNSON, GS
    STOY, SJ
    HUANG, THM
    MONTGOMERY, RR
    BLOOD, 1993, 82 (10) : A149 - A149
  • [34] EXPRESSED FULL-LENGTH VON WILLEBRAND FACTOR CONTAINING A MISSENSE MUTATION LINKED TO TYPE-IIB VON WILLEBRAND DISEASE SHOWS ENHANCED BINDING TO PLATELET GPIB
    KRONER, PA
    KLUESSNDORF, ML
    TRIEU, H
    MONTGOMERY, RR
    CLINICAL RESEARCH, 1991, 39 (02): : A326 - A326
  • [35] ACQUIRED VON-WILLEBRAND SYNDROME DURING HYPOTHYROIDISM - EFFECTS OF THYROXINE TREATMENT ON VON-WILLEBRAND-FACTOR AND FIBRINOLYSIS PARAMETERS
    BORG, JY
    LEVESQUE, H
    VASSE, M
    DALIPHARD, S
    CAILLEUX, N
    MONCONDUIT, M
    COURTOIS, H
    THROMBOSIS AND HAEMOSTASIS, 1993, 69 (06) : 1180 - 1180
  • [36] RATE OF SYNTHESIS OF FACTOR-VIII AND DECAY OF FACTOR-VIII AND VON-WILLEBRAND-FACTOR (VWF) IN SEVERE VON-WILLEBRAND DISEASE (VWD)
    MENACHE, D
    ARONSON, DL
    DARR, F
    MONTGOMERY, RR
    BLOOD, 1994, 84 (10) : A238 - A238
  • [37] PRECISE DIAGNOSIS BY GENE ANALYSIS AND SUCCESSFUL MANAGEMENT OF DELIVERY IN 3 PATIENTS WITH TYPE-IIB VON-WILLEBRAND DISEASE
    TAKAFUTA, T
    FUJIMURA, K
    SHIMOMURA, T
    KAWANO, H
    TAKIMOTO, Y
    FUJIMOTO, T
    NAGAI, N
    OKAMOTO, E
    OHAMA, K
    NAKAMURA, K
    KURAMOTO, A
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 1994, 60 (02) : 163 - 172
  • [38] CHARACTERIZATION OF THE VON-WILLEBRAND-FACTOR GENE (VWF) IN VON-WILLEBRAND DISEASE TYPE-III PATIENTS FROM 24 FAMILIES OF SWEDISH AND FINNISH ORIGIN
    ZHANG, ZP
    BLOMBACK, M
    EGBERG, N
    FALK, G
    ANVRET, M
    GENOMICS, 1994, 21 (01) : 188 - 193
  • [39] DOMINANT TYPE-1 VON-WILLEBRAND DISEASE-ASSOCIATED WITH MUTATED CYSTEINE RESIDUES IN THE D3-DOMAIN OF VON-WILLEBRAND-FACTOR
    EIKENBOOM, JCJ
    REITSMA, PH
    CASTAMAN, G
    TULEY, EA
    BRIET, E
    SADLER, JE
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1170 - 1170
  • [40] NEW MUTATION ILE(546)-]VAL IN A FAMILY WITH TYPE-IIB VON-WILLEBRAND DISEASE CHARACTERIZED BY SPONTANEOUS PLATELET-AGGREGATION, THROMBOCYTOPENIA AND NORMAL LEVELS OF RISTOCETIN COFACTOR
    FEDERICI, AB
    STABILE, F
    CANCIANI, MT
    MIYATA, S
    WARE, JL
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1170 - 1170